|
| 2-PyrazinecarboxaMide, N,N',N''-[2,4,6-boroxintriyltris[[(1R)-3-Methylbutylidene]iMino[(1S)-2-oxo-1-(phenylMethyl)-2,1-ethanediyl]]]tris- Basic information |
Product Name: | 2-PyrazinecarboxaMide, N,N',N''-[2,4,6-boroxintriyltris[[(1R)-3-Methylbutylidene]iMino[(1S)-2-oxo-1-(phenylMethyl)-2,1-ethanediyl]]]tris- | Synonyms: | 2-PyrazinecarboxaMide, N,N',N''-[2,4,6-boroxintriyltris[[(1R)-3-Methylbutylidene]iMino[(1S)-2-oxo-1-(phenylMethyl)-2,1-ethanediyl]]]tris-;(1R,2S)-Bortezomib;Bortezomib-d15;Bortezomib impurity 10/(1R,2S)-Bortezomib;Bortezomib Trimer;Bortezomib ((1R,2S)-Bortezomib);Bortezomib trimer API;Bortezomib Trimer ((1R,2S)-Bortezomib Trimer) | CAS: | 390800-88-1 | MF: | C57H69B3N12O9 | MW: | 1098.67 | EINECS: | 816-310-1 | Product Categories: | | Mol File: | 390800-88-1.mol | |
| 2-PyrazinecarboxaMide, N,N',N''-[2,4,6-boroxintriyltris[[(1R)-3-Methylbutylidene]iMino[(1S)-2-oxo-1-(phenylMethyl)-2,1-ethanediyl]]]tris- Chemical Properties |
Boiling point | 1277.7±65.0 °C(Predicted) | density | 1.26±0.1 g/cm3(Predicted) | storage temp. | -20°C Freezer | solubility | DMSO (Slightly), Methanol (Slightly) | pka | 11.46±0.46(Predicted) | form | Solid | color | White to Off-White |
| 2-PyrazinecarboxaMide, N,N',N''-[2,4,6-boroxintriyltris[[(1R)-3-Methylbutylidene]iMino[(1S)-2-oxo-1-(phenylMethyl)-2,1-ethanediyl]]]tris- Usage And Synthesis |
Uses | Bortezomib Trimer is derived from Bortezomib (B675700), which is the first proteasome inhibitor to be approved by the US FDA for multiple myeloma, a blood cancer. A reversible inhibitor of the 26S proteasome-a barrel-shaped multiprotein particle found in the nucleus and cytosol of all eukaryotic cells. Targets the ubiquitin-proteasome pathway. |
| 2-PyrazinecarboxaMide, N,N',N''-[2,4,6-boroxintriyltris[[(1R)-3-Methylbutylidene]iMino[(1S)-2-oxo-1-(phenylMethyl)-2,1-ethanediyl]]]tris- Preparation Products And Raw materials |
|